Skip to main content
. Author manuscript; available in PMC: 2017 Mar 5.
Published in final edited form as: Eur J Pharmacol. 2016 Feb 3;774:25–33. doi: 10.1016/j.ejphar.2016.01.007

Fig 4.

Fig 4

ACE versus ACE2 selectivity of MLN-4760, (A) racemic mixture, (B) isomer A and (C) isomer B, in human mononuclear cells (n=6). (D) ACE2 activity, and ACE versus ACE2 selectivity of the isomer B of MLN-4760 in human CD34+ cells (n=6). Racemic mixture and the isomers were denoted as MLN-4760-R, MLN-4760-A and MLN-4760-B.